KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 246 filers reported holding KARUNA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,637,124 | -22.7% | 27,424 | -0.8% | 0.22% | -14.1% |
| Q2 2023 | $5,997,204 | -57.2% | 27,656 | -64.2% | 0.26% | -61.0% |
| Q1 2023 | $14,017,159 | -29.3% | 77,170 | -23.5% | 0.67% | -29.9% |
| Q4 2022 | $19,832,745 | -26.4% | 100,930 | -15.8% | 0.96% | -31.1% |
| Q3 2022 | $26,953,000 | +76.8% | 119,828 | -0.6% | 1.39% | +77.3% |
| Q2 2022 | $15,248,000 | -52.8% | 120,528 | -52.7% | 0.78% | -36.3% |
| Q1 2022 | $32,275,000 | +6.7% | 254,556 | +10.3% | 1.23% | +10.3% |
| Q4 2021 | $30,244,000 | +16.6% | 230,872 | +8.9% | 1.12% | +18.5% |
| Q3 2021 | $25,937,000 | +11.3% | 212,022 | +3.7% | 0.94% | +11.0% |
| Q2 2021 | $23,301,000 | +11.9% | 204,414 | +18.1% | 0.85% | +13.0% |
| Q1 2021 | $20,815,000 | – | 173,124 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |